Lundkvist, P., Sjöström, C. D., Amini, S., Pereira, M. J., Johnsson, E., & Eriksson, J. W. (2016). Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes. Diabetes Obes Metab.
শিকাগো স্টাইলে সাইটেশনLundkvist, Per, C. David Sjöström, Sam Amini, Maria J. Pereira, Eva Johnsson, এবং Jan W. Eriksson. "Dapagliflozin Once‐daily and Exenatide Once‐weekly Dual Therapy: A 24‐week Randomized, Placebo‐controlled, Phase II Study Examining Effects On Body Weight and Prediabetes in Obese Adults Without Diabetes." Diabetes Obes Metab 2016.
এমএলএ সাইটেশনLundkvist, Per, et al. "Dapagliflozin Once‐daily and Exenatide Once‐weekly Dual Therapy: A 24‐week Randomized, Placebo‐controlled, Phase II Study Examining Effects On Body Weight and Prediabetes in Obese Adults Without Diabetes." Diabetes Obes Metab 2016.